1-[4-(2-Hydroxy-3-tert-butylaminopropoxy) indol-3-yl(5-acetamido-1-{s}-carboxypentyl)-DL-alanyl]-L-proline dihydrochloride: A new inhibitor of angiotensin-converting enzymes withβ-adrenoblocking properties

R. G. Glushkov, M. D. Mashkovskii, G. K. Skryabin, et al., Khim.-farm. Zh., No. 6, 18–21 (1992). R. G. Glushkov, M. D. Mashkovskii, N. N. Suvorov, et al., ibid., No. 8, 8–12 (1993). N. A. Krit, I. N. Gracheva, M. D. Filatova, and Z. Raissmaim, ibid., No. 7, 44–47 (1991). E. Gross and I. Mayenhofer (eds.), Peptides [Russian translation], Moscow (1983), p. 104. I. Yu. Sakharov, E. A. Dukhanina, and S. M. Danilov, Biokhimiya,51, 946–951 (1986). S. D. Yuzhakov and M. D. Mashkovskii, Khim.-farm. Zh., No. 8, 918–928 (1986). S. D. Yuzhakov, R. G. Glushkov, and M. D. Mashkovskii, ibid., No. 3, 21–31 (1991). G. Allan, D. Cambridge, G. W. Hardy, et al., J. Hypertens.,4, Suppl. 6, 5131–5133 (1986). G. Allan, G. M. Hardy, D. Bull, et al., EP 0234946 (1987). E. Bouley, J. M. Teulon, M. Cares, et al., J. Med. Chem.,29, 100–103 (1986). H. Flohr, H. W. Dahners, and W. Breul, Arzneimittel. Forsch.,25, 985–987 (1975). G. W. Hardy, D. Bull, H. T. Jones, et al., Tetrahedron Lett.,29, No. 7, 799–802 (1988). B. G. Main and H. Tucker, Progr. Med. Chem.,22, 122–163 (1985). A. A. Patchett, E. Harris, M. J. Wyvratt, E. Tristam, EP 0012401 (1984). J. Piqilloud, A. Reinharz, and M. Roth, Biochim. Biophys. Acta.,206, No. 1, 136–142 (1970). A. M. Rudolph and M. A. Heymann, Circulat. Res.,21, 163–184 (1967). R. A. Slater, W. Howson, G. T. G. Swayne, et al., J. Med. Chem.,31, 345–351 (1988). Y. Uchida, M. Nakamura, S. Shimizu, et al., Arch. Int. Pharmacodyn.,262, No. 1, 132–149 (1983).